PRESS RELEASES

• Press Release

  Oct 22, 2020

  Canada’s Prime Minister, Justin Trudeau, Announced Today Precision NanoSystems Will Receive $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19

  Precision Nanosystems, Inc., a global leader in technologies and solutions in genetic medicine, announced today that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and Economic Development’s (ISED) ...

  Read More

• Press Release

  Jul 07, 2020

  eTheRNA Immunotherapies Selects Precision NanoSystems’ NxGen™ Technology for GMP Manufacturing

  eTheRNA Immunotherapies NV (eTheRNA) and Precision NanoSystems Inc. (PNI) have signed a license and supply agreement for the development and manufacture of immunotherapies by eTheRNA using its proprietary mRNA TriMix platform. PNI’s Clinical Solutions team supported eTheRNA...

  Read More

• Press Release

  Jun 17, 2020

  Sirnaomics and Precision NanoSystems Have Formed a Partnership Developing and Manufacturing Novel RNAi drug Candidates Using Precision NanoSystems’ NxGen™ Platform

  Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product. This strategic joint effort includes the execution of a NanoAssemblr^&re...

  Read More

• Press Release

  May 20, 2020

  CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine

  mRNA Vaccines

  CanSinoBIO will license in Precision NanoSystems' proprietary RNA vaccine platform technology. Precision NanoSystems will lead RNA vaccine formulation development. CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials
  
  Read More

• Press Release

  May 07, 2020

  Entos and Precision NanoSystems Partner to Enable GMP Manufacturing of DNA COVID-19 Vaccine | EurekAlert

  DNA Other Formulations Vaccines

  Entos Pharmaceuticals partners with Precision Nanosystems to enable highly scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine and other genetic nanomedicines

  Read More

• Press Release

  Apr 14, 2020

  Precision NanoSystems Appoints Dr. Andrew Geall as Chief Scientific Officer

  mRNA

  Precision NanoSystems (PNI), a global leader in enabling transformative nanomedicines today announced the appointment of Dr. Andrew Geall as the company’s Chief Scientific Officer (CSO).  Dr. Geall has over 20 years’ experience in the development of drug deliv...

  Read More